Social Determinants of Health and Pediatric Brain Tumor Neuropsychological Morbidities
Pediatric Blood & Cancer · 2025
DOI: 10.1002/pbc.32050 ↗At a glance
Journal article in Pediatric Blood & Cancer, 2025. Written by Christina M Sharkey and 4 co-authors. Institution: Department of Psychology, The Catholic University of America, Washington, District of Columbia, USA. Major MEDLINE topics: Social Determinants of Health, Brain Neoplasms, Cancer Survivors. Cited 1 times so far (Crossref); 58 references. Funded by: Health Equity Issues in Transformative Clinical and Translational Research Award, Clinical and Translational Science Institute at Children's National Hospital.
Abstract (original language)
Introduction
Neurocognitive and psychological morbidity risk is well‐documented among pediatric brain tumor (PBT) survivors, yet most known predictors are nonmodifiable, limiting the implementation of a prevention approach. The social and environmental context has been increasingly considered, yet extant research primarily studies individual‐level proxy measures (e.g., insurance). This cross‐sectional study aimed to examine community‐level factors that may contribute to neurocognitive and psychological outcomes in PBT survivors.
Methods
Participants were clinically referred PBT survivors who completed a neuropsychological evaluation ( N = 160, M age = 11.28, SD = 4.69, 57.5% male, 75.0% White), including an age‐appropriate Wechsler scale and parent‐report questionnaires (Behavior Rating Inventory of Executive Function, Child Behavior Checklist). Nationally normed and locally normed Child Opportunity Index (COI) scores were assigned using census tract geocoding. Higher scores reflect more resources and higher opportunity.
Results
Multivariate models including covariates found that National COI rank was associated with intellectual functioning (β = 0.37, 95% CI [0.24, 0.49]), and parent‐reported executive functions (β = −0.20, 95% CI [−0.365, −0.06]), and psychosocial functioning (β = −0.18, 95% CI [−0.35, −0.05]). Local COI rank had similar effects ( p < 0.01). Specific National and Local COI domains had differing effects across outcomes. Radiation treatment was significantly associated with parent‐reported outcomes ( p < 0.05) but not intellectual functioning.
Conclusions
Findings suggest community‐level social determinants of health are associated with neurocognitive and psychological outcomes in PBT survivors. The COI may be useful to inform individual‐level interventions and community‐level policy to mitigate neuropsychological problems following PBT treatment in children from lower‐opportunity communities. Exploration of specific educational, health, or social/economic indicators may highlight targets for a problem‐prevention approach to reducing PBT survivors’ risk for morbidities.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Psychology, The Catholic University of America, Washington, District of Columbia, USA.
- Children's National Hospital and The George Washington University School of Medicine, Washington, District of Columbia, USA.
- Kennedy Krieger Institute, Clinical Trials Unit, Baltimore, Maryland, USA.
ORCID profiles: Karin S Walsh
Funding
- Health Equity Issues in Transformative Clinical and Translational Research Award
- Clinical and Translational Science Institute at Children's National Hospital
Cite
APA
Sharkey, C. M., Nielsen, J., Walsh, K. S., Weisman, H., & Hardy, K. K. (2025). Social Determinants of Health and Pediatric Brain Tumor Neuropsychological Morbidities. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.32050
Vancouver
Sharkey CM, Nielsen J, Walsh KS, Weisman H, Hardy KK. Social Determinants of Health and Pediatric Brain Tumor Neuropsychological Morbidities. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.32050
BibTeX
@article{Sharkey2025,
author = {Sharkey, Christina M and Nielsen, Johanna and Walsh, Karin S and Weisman, Hannah and Hardy, Kristina K},
title = {Social Determinants of Health and Pediatric Brain Tumor Neuropsychological Morbidities},
journal = {Pediatric Blood & Cancer},
year = {2025},
doi = {10.1002/pbc.32050}
}
EUVIMED